A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...

Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted.

A new study reveals a shocking jump in “biological age” among Gen-X, Millennials, and Gen-Z—and it might explain the rise in early-onset cancers.

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) company that is transforming ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...